An E115A Missense Variant in CERS2 Is Associated With Increased Sleeping Energy Expenditure and Hepatic Insulin Resistance in American Indians
Diabetes · 2024
DOI: 10.2337/db23-0690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, 2024. Verfasst von Sascha Heinitz und 11 weiteren Autor:innen. Beteiligte Einrichtung: Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ. Hauptthemen laut MEDLINE: Energy Metabolism, Indians, North American, Insulin Resistance, Liver. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Genetic determinants of interindividual differences in energy expenditure (EE) are largely unknown. Sphingolipids, such as ceramides, have been implicated in the regulation of human EE via mitochondrial uncoupling. In this study, we investigated whether genetic variants within enzymes involved in sphingolipid synthesis and degradation affect EE and insulin-related traits in a cohort of American Indians informative for 24-h EE and glucose disposal rates during a hyperinsulinemic-euglycemic clamp. Association analysis of 10,084 genetic variants within 28 genes involved in sphingolipid pathways identified a missense variant (rs267738, A>C, E115A) in exon 4 of CERS2 that was associated with higher sleeping EE (116 kcal/day) and increased rates of endogenous glucose production during basal (5%) and insulin-stimulated (43%) conditions, both indicators of hepatic insulin resistance. The rs267738 variant did not affect ceramide synthesis in HepG2 cells but resulted in a 30% decrease in basal mitochondrial respiration. In conclusion, we provide evidence that the CERS2 rs267738 missense variant may influence hepatic glucose production and postabsorptive sleeping metabolic rate. Article Highlights
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ.
- Department of Internal Medicine, Clinic for Endocrinology, Nephrology and Rheumatology, University of Leipzig, Leipzig, Germany.
- Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig, Philipp-Rosenthal-Strasse 27, Leipzig, Germany.
- Faculty of Medicine, Rudolf Schönheimer Institute of Biochemistry, Leipzig University, Leipzig, Germany.
- Department of Information Engineering, University of Pisa, Pisa, Italy.
ORCID-Profile: Leslie Baier, Paolo Piaggi
Förderung
- Intramural NIH HHS
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Heinitz, S., Traurig, M., Krakoff, J., Rabe, P., Stäubert, C., Kobes, S., Hanson, R. L., Stumvoll, M., Blüher, M., Bogardus, C., Baier, L., & Piaggi, P. (2024). An E115A Missense Variant in CERS2 Is Associated With Increased Sleeping Energy Expenditure and Hepatic Insulin Resistance in American Indians. Diabetes. https://doi.org/10.2337/db23-0690
Vancouver
Heinitz S, Traurig M, Krakoff J, Rabe P, Stäubert C, Kobes S, et al. An E115A Missense Variant in CERS2 Is Associated With Increased Sleeping Energy Expenditure and Hepatic Insulin Resistance in American Indians. Diabetes. 2024. doi:10.2337/db23-0690
BibTeX
@article{Heinitz2024,
author = {Heinitz, Sascha and Traurig, Michael and Krakoff, Jonathan and Rabe, Philipp and Stäubert, Claudia and Kobes, Sayuko and Hanson, Robert L and Stumvoll, Michael and Blüher, Matthias and Bogardus, Clifton and Baier, Leslie and Piaggi, Paolo},
title = {An E115A Missense Variant in CERS2 Is Associated With Increased Sleeping Energy Expenditure and Hepatic Insulin Resistance in American Indians},
journal = {Diabetes},
year = {2024},
doi = {10.2337/db23-0690}
}
EUVIMED